Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
- PMID: 34796041
- PMCID: PMC8568915
- DOI: 10.4110/in.2021.21.e37
Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation
Abstract
Hepatitis B virus X (HBx) protein has been reported as a key protein regulating the pathogenesis of HBV-induced hepatocellular carcinoma (HCC). Recent evidence has shown that HBx is implicated in the activation of autophagy in hepatic cells. Nevertheless, the precise molecular and cellular mechanism by which HBx induces autophagy is still controversial. Herein, we investigated the molecular and cellular mechanism by which HBx is involved in the TRAF6-BECN1-Bcl-2 signaling for the regulation of autophagy in response to TLR4 stimulation, therefore influencing the HCC progression. HBx interacts with BECN1 (Beclin 1) and inhibits the association of the BECN1-Bcl-2 complex, which is known to prevent the assembly of the pre-autophagosomal structure. Furthermore, HBx enhances the interaction between VPS34 and TRAF6-BECN1 complex, increases the ubiquitination of BECN1, and subsequently enhances autophagy induction in response to LPS stimulation. To verify the functional role of HBx in liver cancer progression, we utilized different HCC cell lines, HepG2, SK-Hep-1, and SNU-761. HBx-expressing HepG2 cells exhibited enhanced cell migration, invasion, and cell mobility in response to LPS stimulation compared to those of control HepG2 cells. These results were consistently observed in HBx-expressed SK-Hep-1 and HBx-expressed SNU-761 cells. Taken together, our findings suggest that HBx positively regulates the induction of autophagy through the inhibition of the BECN1-Bcl-2 complex and enhancement of the TRAF6-BECN1-VPS34 complex, leading to enhance liver cancer migration and invasion.
Keywords: Autophagy; Beclin-1; Hepatitis B virus; Liver neoplasms; TNF receptor-associated factor 6.
Copyright © 2021. The Korean Association of Immunologists.
Conflict of interest statement
Conflicts of Interest: The authors declare no potential conflicts of interest.
Figures
Similar articles
-
p62 is Negatively Implicated in the TRAF6-BECN1 Signaling Axis for Autophagy Activation and Cancer Progression by Toll-Like Receptor 4 (TLR4).Cells. 2020 May 6;9(5):1142. doi: 10.3390/cells9051142. Cells. 2020. PMID: 32384667 Free PMC article.
-
Reactive Oxygen Species-Mediated c-Jun NH2-Terminal Kinase Activation Contributes to Hepatitis B Virus X Protein-Induced Autophagy via Regulation of the Beclin-1/Bcl-2 Interaction.J Virol. 2017 Jul 12;91(15):e00001-17. doi: 10.1128/JVI.00001-17. Print 2017 Aug 1. J Virol. 2017. PMID: 28515304 Free PMC article.
-
AMPKα1 Regulates Lung and Breast Cancer Progression by Regulating TLR4-Mediated TRAF6-BECN1 Signaling Axis.Cancers (Basel). 2020 Nov 6;12(11):3289. doi: 10.3390/cancers12113289. Cancers (Basel). 2020. PMID: 33172060 Free PMC article.
-
Autophagy and apoptosis in liver injury.Cell Cycle. 2015;14(11):1631-42. doi: 10.1080/15384101.2015.1038685. Cell Cycle. 2015. PMID: 25927598 Free PMC article. Review.
-
Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression.IUBMB Life. 2005 Sep;57(9):651-8. doi: 10.1080/15216540500239697. IUBMB Life. 2005. PMID: 16203685 Review.
Cited by
-
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates.Explor Target Antitumor Ther. 2024;5(1):120-134. doi: 10.37349/etat.2024.00209. Epub 2024 Feb 20. Explor Target Antitumor Ther. 2024. PMID: 38464387 Free PMC article. Review.
-
Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential.J Cancer. 2024 Jan 1;15(2):560-576. doi: 10.7150/jca.90059. eCollection 2024. J Cancer. 2024. PMID: 38169510 Free PMC article. Review.
-
β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4.Cell Death Dis. 2023 Jul 13;14(7):422. doi: 10.1038/s41419-023-05945-3. Cell Death Dis. 2023. PMID: 37443143 Free PMC article.
-
The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?Cancers (Basel). 2023 May 17;15(10):2795. doi: 10.3390/cancers15102795. Cancers (Basel). 2023. PMID: 37345131 Free PMC article. Review.
-
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.Cell Biosci. 2023 Jun 7;13(1):102. doi: 10.1186/s13578-023-01038-y. Cell Biosci. 2023. PMID: 37287005 Free PMC article.
References
-
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. - PubMed
-
- Kew MC. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26(Suppl 1):144–152. - PubMed
LinkOut - more resources
Full Text Sources
